Evidence map›Paper›PMID 39448818›Full record

ReviewNature reviews. Neuroscience2024

Neurobiology of attention-deficit hyperactivity disorder: historical challenges and emerging frontiers.

Sanju Koirala, Gracie Grimsrud, Michael A Mooney, Bart Larsen, Eric Feczko, Jed T Elison, Steven M Nelson, Joel T Nigg, Brenden Tervo-Clemmens, Damien A Fair

Abstract readReview
In one paragraph

Review in Nature reviews. Neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. [The microbiota-gut-brain axis in childhood attention-deficit/hyperactivity disorder: mechanisms and therapeutic advances].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sanju KoiralaInstitute of Child Development, University of Minnesota, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0001-8844-4586
Gracie GrimsrudMasonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, USA.
Michael A MooneyDivision of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA.
Bart LarsenMasonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, USA.
Eric FeczkoMasonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, USA.
Jed T ElisonInstitute of Child Development, University of Minnesota, Minneapolis, MN, USA.
Steven M NelsonMasonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, USA.
Joel T NiggDepartments of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
Brenden Tervo-ClemmensMasonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN, USA.
Damien A FairInstitute of Child Development, University of Minnesota, Minneapolis, MN, USA. faird@umn.edu.

Funding

ABCD-USA Consortium: Research ProjectU01DA041148 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Damien A Fair, Rebekah S Huber · 2015 to 2026
$22.3M
Identification of outcome-based sub-populations using deep phenotyping and precision functional mapping across ADHD and ASDR01MH096773 · NIMH · UNIVERSITY OF MINNESOTA · PI DOSENBACH, NICO, FAIR, DAMIEN A · 2012 to 2024
$9.4M
Motion-robust brain MRI for infantsR44MH124567 · NIMH · TURING MEDICAL TECHNOLOGIES INC · PI BERTOLERO, MAXWELL, FAIR, DAMIEN A · 2020 to 2023
$7.3M
ADHD heterogeneity, mechanisms, and risk profileR37MH059105 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI NIGG, JOEL T · 2014 to 2023
$7.0M
Visual biofeedback to reduce head motion during MRI scansR44MH122066 · NIMH · TURING MEDICAL TECHNOLOGIES INC · PI BRUENER, KEN, FAIR, DAMIEN A · 2019 to 2022
$6.2M
Solving the MRI motion problem with Framewise Integrated Real-Time MRI Monitoring (FIRMM) softwareR44MH121276 · NIMH · TURING MEDICAL TECHNOLOGIES INC · PI FAIR, DAMIEN A, ROTHNEY, MEGAN PEARL · 2020 to 2023
$5.4M
Brain trajectories in ADHDR01MH115357 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI FAIR, DAMIEN A, NIGG, JOEL T · 2017 to 2021
$3.8M
Polygenic and environmental contributions to ADHD trajectory and outcome from childhood through adolescenceR01MH131685 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI Michael A Mooney, Molly Nikolas · 2023 to 2026
$3.1M
Leveraging complementary big data methods and patient intervention designs to optimize neural markers of adolescent cannabis useK23DA057486 · NIDA · UNIVERSITY OF MINNESOTA · PI Brenden Craig Tervo-Clemmens · 2023 to 2026
$782k
NIDA NIH HHS K23 DA057486NIDA NIH HHS L30 DA059086NIDA NIH HHS U01 DA041148NIMH NIH HHS R01 MH096773NIMH NIH HHS R01 MH115357NIMH NIH HHS R01 MH131685NIMH NIH HHS R37 MH059105NIMH NIH HHS R44 MH121276NIMH NIH HHS R44 MH122066NIMH NIH HHS R44 MH124567
6 · The paper itself

Abstract

Extensive investigations spanning multiple levels of inquiry, from genetic to behavioural studies, have sought to unravel the mechanistic foundations of attention-deficit hyperactivity disorder (ADHD), with the aspiration of developing efficacious treatments for this condition. Despite these efforts, the pathogenesis of ADHD remains elusive. In this Review, we reflect on what has been learned about ADHD while also providing a framework that may serve as a roadmap for future investigations. We emphasize that ADHD is a highly heterogeneous disorder with multiple aetiologies that necessitates a multifactorial dimensional phenotype, rather than a fixed dichotomous conceptualization. We highlight new findings that suggest a more brain-wide, 'global' view of the disorder, rather than the traditional localizationist framework, which asserts that a limited set of brain regions or networks underlie ADHD. Last, we underscore how underpowered studies that have aimed to associate neurobiology with ADHD phenotypes have long precluded the field from making progress. However, a new age of ADHD research with refined phenotypes, advanced methods, creative study designs and adequately powered investigations is beginning to put the field on a good footing. Indeed, the field is at a promising juncture to advance the neurobiological understanding of ADHD and fulfil the promise of clinical utility.

Indexed as

Attention Deficit Disorder with HyperactivityBrainNeurobiologyAnimalsHumans

Identifiers

PMID39448818
PMCPMC13404203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.